DGX Quest Diagnostics: Bozor kapitallashuvining balans qiymatiga nisbati

Quest Corp (DGX) kompaniyasining rasmiy ramzlari

Quest Diagnostics diagnostikaga bo'lgan barqaror talab tufayli iqtisodiy tebranishlarga chidamlilikni namoyish etmoqda. GURU.Markets konsolidatsiyalashgan grafigida kompaniyaning qiymati va uning kitob kapitalizatsiyasi orasidagi joriy koeffitsient 3.49 ko'rsatkichi metrikaning holatini ifodalashini ko'rsatmoqda. Jim Davis strategiyasi mahalliy laboratoriyalarni sotib olishga tayanadi, ESG standartlarining joriy etilishi esa tibbiy chiqindilarni qayta ishlashni optimallashtiradi.

Quest Corp (DGX): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha
Quest Diagnostics Inc. asosiy tovari

Quest Diagnostics (DGX) uchun laboratoriya tahlillari va sug'urta to'lovlariga bo'lgan barqaror talab bozor kapitalni boshqarish samaradorligi nuqtai nazaridan baholaydigan aktivlar bazasini shakllantiradi. Kompaniyaning bozor qiymatining buxgalteriya qiymatiga nisbatini tahlil qilish orqali investor sof aktivlar qiymatidan yuqori bo'lgan bozor narxi premiumini aniqlaydi, bunda qiymatning oshishi kelajakdagi daromadlarga bo'lgan ishonchni bildiradi, ammo korreksiya xavfini oshiradi.

Asosiy raqobatchilar

A (Agilent Technologies) - Bozor qiymatining balans qiymatiga nisbati|illumina.com (ILMN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati EXAS (Exact Sciences Corporation)|Bozor qiymatining balans qiymatiga koeffitsiyenti Revvity Inc|Bozor kapitallashuvining balans qiymatiga nisbati Bio-Rad Laboratories Inc BIO|Kapitallashuvning balans qiymatiga nisbati Anbio Corp (NNNN)|Bozor kapitallashuvining balans qiymatiga nisbati SHC (Sotera Health Company)|quidel.com - Bozor kapitallashuvining balans qiymatiga nisbati|OPKO Health (OPK) - Bozor qiymatining balans qiymatiga nisbati|CDNA - Kapitallashuvning balans qiymatiga nisbati|MRVI: Bozor kapitallashuvining balans qiymatiga nisbati|FLGT (Fulgent) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Standard BioTools Inc.|Bozor qiymatining balans qiymatiga nisbati cytekbio.com (CTKB)|OraSure - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XGN (exagen.com)|Bozor qiymatining balans qiymatiga nisbati MDXH|Balans qiymatiga nisbatan bozor kapitallashuvi Lucid Diagnostics, Inc LUCD|Bozor kapitallashuvining balans qiymatiga nisbati PRE (Prenetics Global Ltd)|IMDX: Balans qiymatiga nisbatan bozor kapitallashuvi|trinitybiotech.com - Bozor qiymatining balans qiymatiga nisbati|PRPH (ProPhase Labs Inc) - Balans qiymatiga nisbatan bozor kapitallashuvi|Ainos Corp - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati CoDx (CODX)|Kapitallashuvning sof aktivlarga nisbati HSCS|Bozor kapitallashuvining balans qiymatiga nisbati biomerica.com (BMRA)|CDIO: Bozor kapitallashuvining balans qiymatiga nisbati|Virax Biolabs Group Limited - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati BJDX (Bluejay)|Aspira Women's Health Inc (AWH) - Balans qiymatiga nisbatan bozor kapitallashuvi|AXDX - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori CENTOGENE|ENZ - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Fresh2|Bozor kapitallashuvining balans qiymatiga nisbati Genetic Technologies GENE|Kapitallashuvning balans qiymatiga nisbati 23andMe Inc (ME)|Bozor kapitallashuvining balans qiymatiga nisbati PMD